CSPC Pharmaceutical’s rotigotine long-acting injection wins China clinical approval
CSPC Pharmaceutical Group said its rotigotine long-acting injection received clinical trial approval in China.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.